Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma.

Van Waes C, Yu M, Nottingham L, Karin M.

Clin Cancer Res. 2007 Sep 1;13(17):4956-9. No abstract available.

2.
4.

The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.

Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T.

Blood. 2009 Sep 17;114(12):2448-58. doi: 10.1182/blood-2008-09-181008. Epub 2009 Jul 23.

5.

IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.

Araki K, Kawauchi K, Tanaka N.

Oncogene. 2008 Sep 25;27(43):5696-705. doi: 10.1038/onc.2008.184. Epub 2008 Jun 9.

PMID:
18542057
6.

SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB.

Rehman AO, Wang CY.

J Biol Chem. 2008 Jul 18;283(29):19888-94. doi: 10.1074/jbc.M710432200. Epub 2008 Apr 30.

7.

cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma.

Chen Z, Lee TL, Yang XP, Dong G, Loercher A, Van Waes C.

Methods Mol Biol. 2007;383:81-99.

PMID:
18217680
8.

17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells.

Yan SS, Li Y, Wang Y, Shen SS, Gu Y, Wang HB, Qin GW, Yu Q.

Mol Cancer Ther. 2008 Jun;7(6):1523-32. doi: 10.1158/1535-7163.MCT-08-0263.

10.

Understanding the biology of oral cancer and chemoprevention.

Lingen MW.

CDS Rev. 1998 May-Jun;91(4):24-8. Review. No abstract available.

PMID:
9760890
11.
12.

Epothilones induce human colon cancer SW620 cell apoptosis via the tubulin polymerization independent activation of the nuclear factor-kappaB/IkappaB kinase signal pathway.

Lee SH, Son SM, Son DJ, Kim SM, Kim TJ, Song S, Moon DC, Lee HW, Ryu JC, Yoon DY, Hong JT.

Mol Cancer Ther. 2007 Oct;6(10):2786-97.

13.

Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.

Chiang SL, Chen PH, Lee CH, Ko AM, Lee KW, Lin YC, Ho PS, Tu HP, Wu DC, Shieh TY, Ko YC.

Cancer Res. 2008 Oct 15;68(20):8489-98. doi: 10.1158/0008-5472.CAN-08-0823.

14.

NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.

Ferris RL, Grandis JR.

Clin Cancer Res. 2007 Oct 1;13(19):5663-4. Review. No abstract available.

15.

IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis.

DeBusk LM, Massion PP, Lin PC.

Cancer Res. 2008 Dec 15;68(24):10223-8. doi: 10.1158/0008-5472.CAN-08-1833.

16.

The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.

Katsura T, Iwai S, Ota Y, Shimizu H, Ikuta K, Yura Y.

Cancer Gene Ther. 2009 Mar;16(3):237-45. doi: 10.1038/cgt.2008.81. Epub 2008 Oct 24.

PMID:
18949013
17.

Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.

Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M.

Clin Cancer Res. 2009 Apr 1;15(7):2248-58. doi: 10.1158/1078-0432.CCR-08-1383. Epub 2009 Mar 10.

18.

IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.

Schmid JA, Birbach A.

Cytokine Growth Factor Rev. 2008 Apr;19(2):157-65. doi: 10.1016/j.cytogfr.2008.01.006. Epub 2008 Mar 4. Review.

PMID:
18308615
19.

Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B.

von Bülow V, Dubben S, Engelhardt G, Hebel S, Plümäkers B, Heine H, Rink L, Haase H.

J Immunol. 2007 Sep 15;179(6):4180-6.

20.

Local activation of the IkappaK-NF-kappaB pathway in muscle does not cause insulin resistance.

Polkinghorne E, Lau Q, Cooney GJ, Kraegen EW, Cleasby ME.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E316-25. Epub 2007 Nov 20.

Supplemental Content

Support Center